Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05743426
Status:
RECRUITING
Last Update Posted:
2024-03-22
First Post:
2023-02-14
Brief Title:
Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
UNC Lineberger Comprehensive Cancer Center
Study Overview
Official Title:
Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This prospective single-institution observational study explores disease outcomes and toxicities in subjects with gastrointestinal malignancies and sarcoma bone and soft tissue who are being treated with standard-of-care therapies including radiotherapy
Recent advances in treatment approaches affected disease outcomes and toxicities Prospective monitoring of disease outcomes and toxicities using standardized assessments will provide information about recent changes in the standard of care and further refine treatment approaches and prospective clinical trial design
Recent advances in treatment approaches affected disease outcomes and toxicities Prospective monitoring of disease outcomes and toxicities using standardized assessments will provide information about recent changes in the standard of care and further refine treatment approaches and prospective clinical trial design
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None